Unveiling Potential of DNA Polymerase III Inhibitors to Limit Helicobacter pylori

webinar

Thu, 28 Jul 2022, 16:00 CEST (Berlin)

Dr. Sumera Zaib, University of Central Punjab (UCP), Pakistan

Unveiling Potential of DNA Polymerase III Inhibitors to Limit Helicobacter pylori

Helicobacter pylori is the most common gram-negative pathogen that causes chronic gastric inflammation and may lead to gastric cancer. To date, it is hard to eradicate and manage H. pylori infections but with limited combination therapies consistent efforts are in process. However, the immense and repetitive use of the same combination therapies over time made the bacterium resistant to several drugs. Consequently, H. pylori has been considered as a serious threat to human health and require novel antimicrobial drug candidates.

Considering the resistance mechanisms of H. pylori, the DNA polymerase III subunit β (DnaN) was selected as the drug target against which several inhibitors were optimized. Some of the inhibitors were found to be highly potent inhibitors of DnaN as evaluated by utilizing built-in libraries of BioSolveIT, infiniSee, CoLibri, FTrees, SeeSAR’s Inspirator and Molecule Editor Mode, and ReCore. We have discovered a benzamide derivatives as lead class of inhibitor for DnaN via AI- based docking, virtual screening, molecular editing, and toxicological investigation.

Looking forward to your active participation.

Current news

category
Challenge
Martin Schwalm Emerges as Winner of Scientific Challenge Spring 2023
March 15, 2024 14:44 CET
The Scientific Challenge Spring 2023 comes to a conclusion: Martin Schwalm from the University of Frankfurt wins with his project “Identifying Binders to Hijack the Autophagy System for Targeted Protein Degradation”! The study aimed to identify binders for the LC3A protein’s hydrophobic binding site, a crucial target for drug discovery...
Read on
category
Software
Chemical Space Nagivation CLI Tool Updates
March 12, 2024 15:14 CET
Alongside infiniSee 6 ‘Echo’ we release updates to our command line tools that explore and create Chemical Spaces. Computational and tech-savvy medicinal chemists receive several powerful augmentations to the software; these help fine-tuning search parameters to perform even more efficient screening campaigns. New to those features are the new SMARTS...
Read on
category
Software
infiniSee 6 'Echo' Completes Trinity of Chemical Space Navigation
March 11, 2024 13:36 CET
We are more than proud to complete the trinity of Chemical Space navigation with the release of infiniSee Version 6, codenamed ‘Echo’! With Echo’s debut, a new feature called Motif Matcher has been introduced, enabling the screening of incredibly vast Chemical Spaces for compounds exhibiting high maximum common substructure (MCS)...
Read on